SCM
MBII

Seamans Capital Management’s Marrone Bio Innovations, Inc. MBII Stock Holding History

Seamans Capital Management’s Portfolio MBII Stock Details MBII Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		$127K Hold
60,000
– – 0.42% 39
2015
Q2 		$119K Buy
+60,000
New +$170K 0.29% 44

Other funds holding MBII

WRF
Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
SM
Senvest Management New York $3.01B AUM 35.7% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
AIG
American International Group New York $609M AUM 23.67% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Seamans Capital Management's MBII Position: Q3 2015 in Review

Seamans Capital Management held its Marrone Bio Innovations, Inc. (MBII) position steady in Q3 2015 at 60,000 shares worth $127K. The position accounts for 0.42% of the portfolio, ranked #39.

Seamans Capital Management first reported a position in MBII in Q2 2015 and has held it in 2 quarters since. 32 funds tracked by Wall St. Rank hold MBII as of Q3 2015.

  • Seamans Capital Management held 60,000 shares of Marrone Bio Innovations, Inc. worth $127K as of Q3 2015.
  • Seamans Capital Management left its Marrone Bio Innovations, Inc. share count unchanged in Q3 2015.
  • Marrone Bio Innovations, Inc. made up 0.42% of Seamans Capital Management's portfolio in Q3 2015, its #39 holding.
  • Seamans Capital Management first reported a position in Marrone Bio Innovations, Inc. in Q2 2015 and has held it in 2 quarters since.
  • 32 funds tracked by Wall St. Rank held Marrone Bio Innovations, Inc. as of Q3 2015.

Based on Seamans Capital Management's 13F filing for Q3 2015, filed 12 Nov 2015.